New Versions of Phoenix WinNonlin, NLME, Connect and the IVIVC Toolkit for Model Based Drug Development now available

Pharsight announces the availability of a new release of the Phoenix platform for integrated PK/PD modeling and simulation. 

The Phoenix platform combines four tools within a single graphical user interface to create a fully integrated, regulatory compliant modeling environment. The updated products include: 

• 
  
• Phoenix WinNonlin 6.2: perform NCA and PK/PD modeling and simulation.
• 
  
• Phoenix NLME 1.1: perform population PK/PD modeling and simulation.
• 
  
• IVIVC Toolkit 2.0 for Phoenix WinNonlin: create in vivo/in vitro correlations to design more effective bioavailability or bioequivalence studies. 
• 
  
  Phoenix Connect 1.2: integrate 3rd party software packages such as SAS, S+, R, NONMEM and SigmaPlot
• 
  

Upgrading to the latest version of Phoenix platform PK/PD modeling and analysis software is easy, and free for current customers, so upgrade your licensed software today!  In this latest release, all software tools in Phoenix benefit from a set of enhancements made to the underlying platform. 

The new release will support Windows 7, and offers a separately licensed Job Management System that will allow users to remotely execute compute intensive jobs. A great number of enhancements to workflows, plotting, tables, licensing and the overall user experience have been included. In addition, each of the individual tools contains enhancements that are specific to each tool, such as improvements to the analytical engines for population PK/PD modeling.